
Royalty Pharma
Buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry.
Market cap
$15.1b
Enterprise value
$20.9b
Share price
$36.03 RPRX
Recent deals
Authorizing premium user...
Buyer of biopharmaceutical royalties and a leading funder of innovation across the biopharmaceutical industry.